It does not help that poorly understood and insufficiently validated markers such as amyloids and tau are given more weight than both clinical judgment and structural and functional image-based examination as conducted in the 2018 diagnostic ATN classification, in which “A”, “T”, and “N” stand for “amyloid”, “tau”, and “neuropathology”, respectively [13]. Here, MAPT is linked to amyloidosis.